Select your destination
Continue to Radiometer MedicalCO2 monitoring of MND patients at the Royal Preston Hospital
TCM5 BASIC chosen as a non-invasive method to monitor respiratory disease progression in MND patients
Inaugurated in 1993, the Centre has a long track record of delivering high quality clinical research. Choosing Radiometer's TCM5 BASIC to monitor respiratory disease progress in MND patients lead to earlier conversations about patient treatment and improved quality of care.
Monitoring disease progression is a big part of our role. It helps us make decisions early on and involve patients in the care decision making process.
- Pauline Callagher, Specialist Nurse
Monitoring carbon dioxide levels
Before the TCM5 BASIC, the nurses at the Centre would “frequently have to wake patients up and quickly draw blood to be sent off to the lab for blood gas analysis. Now the TCM5 BASIC provides a full overnight trace of the blood gas levels of a patient,” explains physiotherapist Tracey McDonald.
It is well recognised that patients with MND experience progressive hypoventilation…. Patients in our Centre have access to nocturnal capnography and this allows us to assess nocturnal hypoventilation and thereby facilitate provision of timeline and optimal care.
- Professor Suresh Chhetri, Consultant Neurologist, Lancashire Teaching Hospitals NHS Foundation Trust
Getting the timing right
“The TCM5 BASIC adds information about the right timing of when we need to be talking about whether the patient wants to be ventilated, whether they need someone to sit with them all night or whether they need to go into 24 hour-care,” explains McDonald.
A monitoring system tailored to the needs of a multidisciplinary care team
About the hospital
- The Lancashire and South Cumbria MND Care and Research Centre serves an approximate population of 1.6 million in Lancashire and South Cumbria
- The Centre was one of the first established MNC Care and Research Centres
- The Centre participates in a number of multicentre research studies and clinical trials
- The Centre is supported by the Sydney Driscoll Neuroscience Foundation and George Barton Motor Neurone Disease Trust
Cookies are used on this website
Use of cookiesPlease enter a valid email
We will be sending an e-mail invitation to you shortly to sign in using Microsoft Azure AD.
It seems that your e-mail is not registered with us
Please click "Get started" in the e-mail to complete the registration process
Radiometer is using Microsoft AZURE Active Directory to authenticate users
Radiometer uses Azure AD to provide our customers and partners secure access to documents, resources, and other services on our customer portal.
If your organization is already using Azure AD you can use the same credentials to access Radiometer's customer portal.
Key benefits
- Allow the use of existing Active Directory credentials
- Single-sign on experience
- Use same credentials to access future services
Request access
You will receive an invitation to access our services via e-mail when your request has been approved.
When you accept the invitation, and your organization is already using AZURE AD, you can use the same credentials to access Radiometer's customer portal. Otherwise, a one-time password will be sent via e-mail to sign in.